TG Therapeutics Inc’s filing revealed that its Director Echelard Yann acquired Company’s shares for reported $0.49 million on Nov 05 ’24. In the deal valued at $24.48 per share,20,000 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Lonial Sagar sold 16,348 shares, generating $275,791 in total proceeds. Upon selling the shares at $16.87, the Director now owns 105,195 shares.
Before that, Lonial Sagar sold 9,585 shares. TG Therapeutics Inc shares valued at $157,098 were divested by the Director at a price of $16.39 per share. As a result of the transaction, Lonial Sagar now holds 99,293 shares, worth roughly $2.57 million.
TD Cowen initiated its TG Therapeutics Inc [TGTX] rating to a Buy in a research note published on October 29, 2024; the price target was $50. A number of analysts have revised their coverage, including Goldman’s analysts, who increased its forecast for the stock in early August from “a Sell” to “a Neutral”. BofA Securities started covering the stock on May 20, 2022. It rated TGTX as “an Underperform”.
Price Performance Review of TGTX
On Tuesday, TG Therapeutics Inc [NASDAQ:TGTX] saw its stock jump 6.16% to $25.86. Over the last five days, the stock has gained 0.58%. TG Therapeutics Inc shares have risen nearly 51.41% since the year began. Nevertheless, the stocks have risen 133.82% over the past one year. While a 52-week high of $26.99 was reached on 11/01/24, a 52-week low of $9.81 was recorded on 02/21/24. SMA at 50 days reached $23.56, while 200 days put it at $18.73.
Levels Of Support And Resistance For TGTX Stock
The 24-hour chart illustrates a support level at 24.30, which if violated will result in even more drops to 22.74. On the upside, there is a resistance level at 26.72. A further resistance level may holdings at 27.58. The Relative Strength Index (RSI) on the 14-day chart is 58.14, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.21, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 25.80%. Stochastics %K at 70.70% indicates the stock is a holding.
How much short interest is there in TG Therapeutics Inc?
A steep rise in short interest was recorded in TG Therapeutics Inc stocks on 2024-10-15, growing by 2.65 million shares to a total of 32.48 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 29.84 million shares. There was a rise of 8.15%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 23, 2022 when B. Riley Securities resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $35.
